Latest Insights - page 84 | BiopharmaTrend

Emerging AI Player in the Drug Discovery Race Promises to Screen Ultra-large Chemical Spaces Within Hours

Receptor.AI, a UK-based start-up company which integrates artificial intelligence (AI) into drug discovery, just announced the public launch of the SaaS platform for AI-accelerated virtual screening of multi-billion chemical spaces …

Continue ›››

AI Hunt for ALS Treatment Continues With 28 Novel Targets Revealed by Insilico Medicine

Insilico Medicine identified 28 new targets for the treatment of amyotrophic lateral sclerosis (ALS) using its proprietary AI-driven platform PandaOmics. Previously unreported 8 genes were shown to have functional connection …

Continue ›››

Paradigm4 Brings Single Cell Community Closer to Custom-Made Cell Atlas

Paradigm4 just launched an integral component of the REVEAL: Single Cell - a Precision Cell AtlasTM, which enables researchers to generate their own cell atlas from single cell data. Now …

Continue ›››

In the Largest Study, AI Found To Increase Efficiency of Breast Cancer Screening -- When Combined with Human Intelligence

Today, German artificial intelligence (AI) startup Vara published peer-reviewed research in Lancet Digital Health highlighting how a combination of AI and radiologists’ decision-making for analyzing breast cancer screenings can significantly …

Continue ›››

How Data-sharing Technologies Bolster AI Progress in Medical Research

While artificial intelligence (AI) already proved to be a groundbreaking thing in many industries (robotics, finance, surveillance, cyber security, self-driving cars to name just a few), the pharmaceutical industry is …

Continue ›››

Owkin Announces First-ever Large-scale Use of AI to Enhance Clinical Trials

A French-American healthcare unicorn Owkin, which applies artificial intelligence (AI) and federated learning frameworks to drug discovery, has just announced a strategic collaboration deal with Bristol Myers Squibb to use …

Continue ›››

The First Innovation in Treatment of Low Testosterone in Men Since 1930th

Acesis Biomed, a biotechnology company based in the US and the UK, is developing an innovative solution for the treatment of low testosterone in men in over 80 years. Low …

Continue ›››

Insilico Medicine Snaps Up $60M to Create Robotic Lab of the Future

Hong Kong-based pioneer of the artificial intelligence (AI)-driven drug discovery, a clinical stage biotech Insilico Medicine, has completed a $60 million Series D financing from a syndicate of newly joined …

Continue ›››

Professor Sidney Altman

Because of the war I’ve missed the news about the death of Sidney Altman on April 5, 2022. Altman is outstanding researcher, who first discovered the catalytical properties of RNA. …

Continue ›››

Virtual Reality in Drug Discovery: More Useful Than You Probably Think

Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design is an interesting and emerging technological opportunity.

Continue ›››

Gearing AI to Fight Pandemics: a Novel COVID-19 Drug Candidate Announced

Hong Kong-based clinical stage drug discovery company Insilico Medicine just announced the nomination of a novel preclinical drug candidate for treating COVID-19, de novo designed using the company’s artificial intelligence …

Continue ›››

Better Data Management is Key for Clinical Trials: Interview with Raj Indupuri, CEO, eClinical Solutions

The digitalization of clinical trials and the adoption of artificial intelligence (AI) has been a hot topic for a number of years now. Below is my interview with Mr. Raj …

Continue ›››